• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤坏死因子超家族成员 15 启动子多态性增加小细胞肺癌易感性:一项病例对照研究。

TNFSF15 promoter polymorphisms increase the susceptibility to small cell lung cancer: a case-control study.

机构信息

College of Life Science, North China University of Science and Technology, Tangshan, 063210, China.

School of Public Health, North China University of Science and Technology, Tangshan, 063210, China.

出版信息

BMC Med Genet. 2019 Feb 8;20(1):29. doi: 10.1186/s12881-019-0762-6.

DOI:10.1186/s12881-019-0762-6
PMID:30736740
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6368786/
Abstract

BACKGROUND

Tumor necrosis factor superfamily member 15 (TNFSF15) is closely related to tumorigenesis and development. This study aimed to investigate the correlations between TNFSF15 polymorphisms and genetic susceptibility to lung cancer.

METHODS

This case-control study included 209 small cell lung cancer patients (SCLC), 340 non- small cell lung cancer patients (NSCLC) and 460 health controls. TNFSF15-638 A > G and - 358 T > C polymorphisms were genotyped by polymerase chain reaction-restrictive fragment length polymorphism (PCR-RFLP) analysis. Odds ratio (OR) and 95% confidence interval (95% CI) were estimated by unconditional logistic regression.

RESULTS

Our results showed that subjects carrying the TNFSF15-638GG genotype or -358CC genotype were more likely to develop SCLC (-638GG, OR = 1.84, 95%CI = 1.13-2.99; -358CC, OR = 2.44, 95%CI = 1.46-4.06), but not NSCLC (P > 0.05). In stratified analysis, -638GG genotype was related to SCLC among males (OR = 1.95, 95%CI = 1.09-3.45, P = 0.023) and older patients (OR = 2.93, 95%CI = 1.44-8.68, P = 0.006). However, -358CC genotype was associated with SCLC among females (OR = 8.42, 95%CI = 2.22-31.89, P = 0.002) and older subjects with OR (95%CI) of 11.04 (3.57-34.15) (P < 0.001). Moreover, TNFSF15 -358CC was linked with a higher risk of SCLC among non-smokers (OR = 2.54, 95%CI = 1.20-5.35, P = 0.015) but not among smokers (OR = 1.88, 95%CI = 0.92-3.84, P = 0.086).

CONCLUSION

These findings highlight the importance of TNFSF15 polymorphisms in the development of SCLC.

摘要

背景

肿瘤坏死因子超家族成员 15(TNFSF15)与肿瘤的发生和发展密切相关。本研究旨在探讨 TNFSF15 多态性与肺癌遗传易感性的相关性。

方法

这项病例对照研究纳入了 209 例小细胞肺癌(SCLC)患者、340 例非小细胞肺癌(NSCLC)患者和 460 名健康对照。采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)分析方法检测 TNFSF15-638A>G 和-358T>C 多态性。采用非条件 logistic 回归估计比值比(OR)和 95%置信区间(95%CI)。

结果

我们的结果表明,携带 TNFSF15-638 GG 基因型或-358 CC 基因型的个体更易患 SCLC(-638 GG,OR=1.84,95%CI=1.13-2.99;-358 CC,OR=2.44,95%CI=1.46-4.06),但与 NSCLC 无关(P>0.05)。在分层分析中,-638 GG 基因型与男性(OR=1.95,95%CI=1.09-3.45,P=0.023)和老年患者(OR=2.93,95%CI=1.44-8.68,P=0.006)的 SCLC 相关。然而,-358 CC 基因型与女性(OR=8.42,95%CI=2.22-31.89,P=0.002)和老年患者(OR(95%CI)为 11.04(3.57-34.15)(P<0.001)的 SCLC 相关。此外,TNFSF15-358 CC 与非吸烟者(OR=2.54,95%CI=1.20-5.35,P=0.015)的 SCLC 风险升高相关,而与吸烟者(OR=1.88,95%CI=0.92-3.84,P=0.086)无关。

结论

这些发现强调了 TNFSF15 多态性在 SCLC 发生发展中的重要性。

相似文献

1
TNFSF15 promoter polymorphisms increase the susceptibility to small cell lung cancer: a case-control study.肿瘤坏死因子超家族成员 15 启动子多态性增加小细胞肺癌易感性:一项病例对照研究。
BMC Med Genet. 2019 Feb 8;20(1):29. doi: 10.1186/s12881-019-0762-6.
2
TNFSF15 is likely a susceptibility gene for systemic lupus erythematosus.肿瘤坏死因子超家族成员 15 可能是系统性红斑狼疮的易感基因。
Gene. 2018 Sep 5;670:106-113. doi: 10.1016/j.gene.2018.05.098. Epub 2018 May 24.
3
Functional genetic variants of TNFSF15 and their association with gastric adenocarcinoma: a case-control study.肿瘤坏死因子配体超家族成员15(TNFSF15)的功能基因变异及其与胃腺癌的关联:一项病例对照研究
PLoS One. 2014 Sep 24;9(9):e108321. doi: 10.1371/journal.pone.0108321. eCollection 2014.
4
TLR4 regulatory region variants reduce the susceptibility of small-cell lung cancer in Chinese population.TLR4 调控区变异降低中国人群小细胞肺癌的易感性。
Eur J Cancer Prev. 2022 Jul 1;31(4):363-368. doi: 10.1097/CEJ.0000000000000737. Epub 2022 May 13.
5
Polymorphisms are Associated with Graves' Disease and Graves' Ophthalmopathy in a Han Chinese Population.多态性与汉族人群中的 Graves 病和 Graves 眼病有关。
Curr Eye Res. 2020 Jul;45(7):888-895. doi: 10.1080/02713683.2019.1705494. Epub 2019 Dec 27.
6
Genetic analysis of TNFST15 variants in ankylosing spondylitis.强直性脊柱炎中TNFST15变体的遗传分析。
Int J Clin Exp Pathol. 2015 Nov 1;8(11):15210-5. eCollection 2015.
7
A common CD55 rs2564978 variant is associated with the susceptibility of non-small cell lung cancer.常见的CD55基因rs2564978变异与非小细胞肺癌的易感性相关。
Oncotarget. 2017 Jan 24;8(4):6216-6221. doi: 10.18632/oncotarget.14053.
8
TNF-alpha, TNF-beta, IL-6, and IL-10 polymorphisms in patients with lung cancer.肺癌患者的肿瘤坏死因子-α、肿瘤坏死因子-β、白细胞介素-6和白细胞介素-10基因多态性
Dis Markers. 2005;21(3):157-65. doi: 10.1155/2005/707131.
9
Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer.肿瘤坏死因子-α基因多态性与非小细胞肺癌易感性及严重程度的关联
Lung Cancer. 2006 Apr;52(1):15-20. doi: 10.1016/j.lungcan.2005.11.011. Epub 2006 Feb 14.
10
Association of TNFSF15 with Crohn's disease in Koreans.韩国人中TNFSF15与克罗恩病的关联。
Am J Gastroenterol. 2008 Jun;103(6):1437-42. doi: 10.1111/j.1572-0241.2007.01752.x. Epub 2008 Apr 16.

引用本文的文献

1
The genomic landscape of the immune system in lung cancer: present insights and continuing investigations.肺癌中免疫系统的基因组格局:当前见解与持续研究
Front Genet. 2024 Jun 25;15:1414487. doi: 10.3389/fgene.2024.1414487. eCollection 2024.
2
Role of TNFSF15 variants in oral cancer development and clinicopathologic characteristics.肿瘤坏死因子超家族成员 15 变体在口腔癌发生发展及临床病理特征中的作用。
J Cell Mol Med. 2022 Nov;26(21):5452-5462. doi: 10.1111/jcmm.17569. Epub 2022 Oct 13.
3
Functional genetic variants in complement component 7 confer susceptibility to gastric cancer.

本文引用的文献

1
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.估算 2018 年全球癌症发病率和死亡率:GLOBOCAN 来源和方法。
Int J Cancer. 2019 Apr 15;144(8):1941-1953. doi: 10.1002/ijc.31937. Epub 2018 Dec 6.
2
Tobacco Smoking-Associated Alterations in the Immune Microenvironment of Squamous Cell Carcinomas.烟草相关的鳞状细胞癌免疫微环境改变。
J Natl Cancer Inst. 2018 Dec 1;110(12):1386-1392. doi: 10.1093/jnci/djy060.
3
NF-kB2 Genetic Variations are Significantly Associated with Non-Small Cell Lung Cancer Risk and Overall Survival.
补体成分7中的功能性基因变异赋予胃癌易感性。
PeerJ. 2022 Jan 18;10:e12816. doi: 10.7717/peerj.12816. eCollection 2022.
4
Relationship between vascular endothelial growth factor -2578C > a gene polymorphism and lung cancer risk: a meta-analysis.血管内皮生长因子 -2578C > a 基因多态性与肺癌风险的关系:荟萃分析。
BMC Med Genet. 2020 Jan 29;21(1):17. doi: 10.1186/s12881-019-0938-0.
NF-κB2 基因变异与非小细胞肺癌风险和总生存期显著相关。
Sci Rep. 2018 Mar 27;8(1):5259. doi: 10.1038/s41598-018-23324-3.
4
Promoter Polymorphism rs2333227 Enhances Malignant Phenotypes of Colorectal Cancer by Altering the Binding Affinity of AP-2α.启动子多态性 rs2333227 通过改变 AP-2α 的结合亲和力增强结直肠癌的恶性表型。
Cancer Res. 2018 May 15;78(10):2760-2769. doi: 10.1158/0008-5472.CAN-17-2538. Epub 2018 Mar 14.
5
Progression of undiagnosed cutaneous lymphoma after anti-tumor necrosis factor-alpha therapy.抗肿瘤坏死因子-α治疗后未诊断的皮肤淋巴瘤进展。
J Am Acad Dermatol. 2018 Jun;78(6):1068-1076. doi: 10.1016/j.jaad.2017.12.068. Epub 2018 Jan 4.
6
Genetic Variants in the Promoter Region of and the Risk of Breast Cancer.[基因名称]启动子区域的遗传变异与乳腺癌风险
Biomed Res Int. 2017;2017:2352874. doi: 10.1155/2017/2352874. Epub 2017 Jun 12.
7
The functional variant rs34330 of CDKN1B is associated with risk of neuroblastoma.CDKN1B 的功能性变体 rs34330 与神经母细胞瘤的风险相关。
J Cell Mol Med. 2017 Dec;21(12):3224-3230. doi: 10.1111/jcmm.13226. Epub 2017 Jun 30.
8
A case-control study about the association between vascular endothelial growth inhibitor gene polymorphisms and breast cancer risk in female patients in Northeast China.一项关于中国东北地区女性患者血管内皮生长抑制因子基因多态性与乳腺癌风险关联的病例对照研究。
Chin J Cancer Res. 2016 Aug;28(4):435-43. doi: 10.21147/j.issn.1000-9604.2016.04.07.
9
Cancer statistics in China, 2015.《中国癌症统计数据 2015》
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.
10
Soluble TL1A is sufficient for activation of death receptor 3.可溶性TL1A足以激活死亡受体3。
FEBS J. 2016 Jan;283(2):323-36. doi: 10.1111/febs.13576. Epub 2015 Nov 24.